Medtech

  • Israeli tumour-beating pioneer lures life sciences VC to C-suite

    Israeli medical devices firm Alpha Tau Medical has lured Medstrada CEO Ruth Alon to its c-suite. The Nasdaq-listed developer of alpha-radiation cancer therapy believes the seasoned senior executive - with stints in venture capital and Silicon Valley consulting - will bring her extensive financial and strategic operations expertise to bear on the Tel Aviv-based firm. [...]

  • Breakthrough AI tool predicts when heart attacks will strike

    An AI-enabled tool that can predict when heart attacks will strike has been devised by researchers at Cedars-Sinai Medical Center, Los Angeles. In tests, the tool accurately indicated which patients would experience a heart attack in five years, based on the amount and composition of plaque in arteries that supply blood to the heart. The [...]

  • Life sciences firms failing to grasp connected health bonanza

    The life sciences sector’s failure to adequately provide ‘connected health’ products and services to patients will prove a boon to Big Tech, according to a new report. Capgemini’s research reveals that, despite high ambitions, only a few life sciences organisations have the digital, technical and collaborative abilities to realise the potential of connected health. And less [...]

  • Driving ICT collaboration and innovation into public health 

    Health Tech World reports on how NOE CPC and its pioneering collaborative model is helping to support the NHS in driving technology developments. Public health has always had an insatiable appetite for new ideas and technologies; but this has intensified during the last two years, out of the pressure generated by the pandemic. For innovators [...]

  • Harried GPs gain data insights into patient demand drivers

    A healthcare system covering 800,000 patients in southern England is using advanced data analytics for over-stretched GPs to identify patient demand drivers. Frimley Health and Care Integrated Care System (ICS) uses EMIS-X Analytics, an advanced data analytics platform from primary care software provider EMIS, tapping data from the local shared care record, aided by population [...]

  • World’s first dedicated lung scanner launched

    Patients with lung conditions can now access the world’s first and only dedicated lung scanner. The technology, developed and built in Australia by global medical technology company 4DMedical, at the Prince of Wales Hospital, Sydney, utilises an automated scanning process to produce detailed lung function information in real time. The XV Scanner is backed by [...]

  • FDA orders Philips to notify customers about health tech recalls

    The FDA has ordered Philips to notify patients of last year's recall of certain 'Respironics' products after what it calls "inadequate" attempts to do so far. In June last year, Philips Respironics recalled certain ventilators, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) machines. The recall came amid the identification of the unreasonable risk [...]

  • Tips on effective hypertension management through online consultation

    Doctors regard hypertension or high blood pressure as a silent killer. People may have high blood pressure but are entirely unaware of their condition. As most individuals do not experience any symptoms, many resume their daily lives without receiving the treatment to ensure their longevity and overall health. Whether you are suffering from hypertension or [...]

  • Startups selected for AWS Inaugural Healthcare Accelerator Programme in the UK

    The first Amazon Web Services Healthcare Accelerator in the UK has selected start-ups representing a variety of healthcare solutions to join. The first Amazon Web Services (AWS) Healthcare Accelerator in the UK cohort represents a variety of healthcare solutions backed by diverse leadership, with 50 per cent of the cohort identifying as women-owned or minority-owned [...]

  • Scenic Biotech announces financing to progress pipeline of genetic modifiers

    Scenic will now advance its lead QPCTL small molecule immuno-oncology program into the clinic